ImClone 'Eager' for Erbitux Data Release
The biotech stock has fallen ahead of ASCO on doubts about the FLEX study, but management remains bullish. 1 month ago
TheStreet Click here to Read the Full Story
Digg
del.icio.us
Reddit
Stumble
Newsvine
FacebookHome|About| 
Subscribe to RSS feeds|Product Blog|Contact|Site Map|Help
Copyright© 2008 nobosh LLC. All Rights Reserved